Select Page

Author: Ryan Voyles

Sagent Pharmaceuticals Announces Acquisition of Raleigh Manufacturing Site

Nichi-Iko Pharmaceutical Co., Ltd. ("Nichi-Iko") and Sagent Pharmaceuticals, Inc., a Nichi-Iko Group Company ("Sagent"), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that Sagent has acquired an FDA-approved manufacturing site in Raleigh, North Carolina, from Xellia Pharmaceuticals ("Xellia"). Financial terms of the transaction have not been disclosed.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Read More

Pharmacy benefit managers face scrutiny during hearing on prescription drugs

Lawmakers questioned whether more oversight is necessary of pharmacy benefit managers at a three-and-a-half hour joint meeting of the House Prescription Drug Affordability and Accessibility and Insurance committees Friday in Chicago.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Read More

Planned Parenthood of Illinois wouldn’t participate in Title X if new rule goes into effect

Planned Parenthood of Illinois wouldn't be able to provide care under a federal family planning grant program if a new federal rule goes into effect barring those receiving money from referring patients for abortions in most cases.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Read More

Advertise With Us

 
health-news-illinois-advertisers-01